Advisors Preferred, LLC Amgen Inc Transaction History

Advisors Preferred, LLC

$645 Million
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$268.87 - $324.56 $41,405 - $49,982	-154 Reduced 9.91%	1,400 $398,000
Q4 2023 Jan 24, 2024	SELL	$255.7 - $288.46 $178,478 - $201,345	-698 Reduced 30.99%	1,554 $447,000
Q3 2023 Nov 07, 2023	BUY	$218.65 - $271.46 $12,681 - $15,744	58 Added 2.64%	2,252 $605,000
Q2 2023 Aug 04, 2023	BUY	$214.27 - $253.37 $41,996 - $49,660	196 Added 9.81%	2,194 $487,000
Q1 2023 May 03, 2023	SELL	$225.79 - $275.2 $56,899 - $69,350	-252 Reduced 11.2%	1,998 $483,000
Q4 2022 Feb 08, 2023	SELL	$229.03 - $291.01 $1.85 Million - $2.35 Million	-8,091 Reduced 78.24%	2,250 $590,000
Q3 2022 Nov 07, 2022	BUY	$224.46 - $253.15 $1.71 Million - $1.93 Million	7,616 Added 279.49%	10,341 $2.38 Million
Q2 2022 Aug 11, 2022	BUY	$230.71 - $256.74 $161,497 - $179,718	700 Added 34.57%	2,725 $663,000
Q1 2022 May 09, 2022	BUY	$219.27 - $242.57 $45,608 - $50,454	208 Added 11.45%	2,025 $492,000
Q4 2021 Feb 07, 2022	SELL	$198.88 - $227.6 $29,832 - $34,140	-150 Reduced 7.63%	1,817 $412,000
Q3 2021 Oct 27, 2021	BUY	$212.27 - $248.7 $52,430 - $61,428	247 Added 14.36%	1,967 $421,000
Q2 2021 Jul 26, 2021	SELL	$233.58 - $259.14 $24,525 - $27,209	-105 Reduced 5.75%	1,720 $425,000
Q1 2021 May 07, 2021	SELL	$221.91 - $258.6 $668,392 - $778,903	-3,012 Reduced 62.27%	1,825 $455,000
Q4 2020 Feb 03, 2021	BUY	$216.38 - $257.67 $710,808 - $846,445	3,285 Added 211.66%	4,837 $1.1 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $127,414 - $141,695	543 Added 53.82%	1,552 $394,000
Q2 2020 Aug 11, 2020	BUY	$197.81 - $242.74 $199,590 - $244,924	1,009 New	1,009 $257,000
Q1 2020 Apr 20, 2020	SELL	$182.24 - $241.7 $283,929 - $376,568	-1,558 Closed	0 $0
Q4 2019 Jan 21, 2020	BUY	$189.21 - $243.2 $294,789 - $378,905	1,558 New	1,558 $376,000
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $28,379 - $34,005	-163 Closed	0 $0
Q2 2019 Aug 06, 2019	BUY	$166.7 - $195.41 $27,172 - $31,851	163 New	163 $30,000
Q3 2018 Oct 25, 2018	SELL	$185.29 - $208.89 $19,270 - $21,724	-104 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$166.05 - $186.51 $17,269 - $19,397	104 New	104 $19,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Preferred, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisors Preferred, LLC with notifications on news.

Account